30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ali Behbahani

Insider profile

Currently holds positions in CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director CRISPR Therapeutics AG April 1, 2015 -
Independent Director Genocea Biosciences Inc Feb. 8, 2018 -
Non-Executive Independent Director Adaptimmune Therapeutics PLC Sept. 1, 2014 -
Independent Director Nevro Corp Sept. 1, 2014 - March 19, 2019

Ali Behbahani's trades of SpyGlass Pharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-11 2026-02-09 B Purchase
11,416 +27.1%
230.62
US$3,961,577
11,416 +27.1% 230.62 US$3,961,577
2025-10-06 2025-10-02 S Sale
59,607 +38.5%
161.39
US$1,342,890
59,607 +38.5% 161.39 US$1,342,890
2025-10-06 2025-10-02 S Sale
74,846 +20.0%
346.87
US$1,083,257
74,846 +20.0% 346.87 US$1,083,257
2025-10-06 2025-10-02 S Sale
280 -0.1%
6.75
US$1,890
280 -0.1% 6.75 US$1,890
2025-10-06 2025-10-02 S Sale
280 -0.0%
6.75
US$1,890
280 -0.0% 6.75 US$1,890
2025-08-19 2025-08-18 S Sale
14,671,794 -100.0%
0.01
US$176,062
14,671,794 -100.0% 0.01 US$176,062
2025-08-19 2025-08-15 S Sale
4,828,206 -24.8%
0.01
US$53,110
4,828,206 -24.8% 0.01 US$53,110
2024-11-29 2024-11-29
US CVRx Inc (CVRX)
PrS Proposed sale
21,837
15.30
US$334,106
21,837 15.30 US$334,106
2024-11-18 2024-11-18
US CVRx Inc (CVRX)
PrS Proposed sale
9
14.07
US$127
9 14.07 US$127
2024-09-17 2024-09-16 B Purchase
500,000 +16.1%
16.00
US$8,000,000
500,000 +16.1% 16.00 US$8,000,000
2023-07-19 2023-07-17 B Purchase
333,333 +1.4%
3.00
US$999,999
333,333 +1.4% 3.00 US$999,999
2023-07-06 2023-07-05 B Purchase
1,000,000 +29.0%
5.00
US$5,000,000
1,000,000 +29.0% 5.00 US$5,000,000
2022-05-26 2022-05-25 S Sale
4,445,093 -100.0%
0.08
US$362,720
4,445,093 -100.0% 0.08 US$362,720
2022-05-26 2022-05-24 S Sale
5,931,843 -57.2%
0.07
US$387,943
5,931,843 -57.2% 0.07 US$387,943
2022-04-13 2022-04-11 B Purchase
948,948 +inf%
1.90
US$1,803,001
948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2,631,578 +33.8%
1.90
US$4,999,998
2,631,578 +33.8% 1.90 US$4,999,998
2021-10-19 2021-10-18 B Purchase
1,851,852
0.00
US$0
1,851,852 0.00 US$0
2021-03-18 2021-03-16 B Purchase
5,714,285 +114.3%
1.75
US$9,999,999
5,714,285 +114.3% 1.75 US$9,999,999
2020-12-07 2020-12-04 B Purchase
4,398,602 +214.3%
0.62
US$2,735,930
4,398,602 +214.3% 0.62 US$2,735,930
2020-09-22 2020-09-18 B Purchase
769,230 +33.6%
13.00
US$9,999,990
769,230 +33.6% 13.00 US$9,999,990
2020-07-28 2020-07-24 B Purchase
3,151,260 +43.6%
2.25
US$7,090,335
3,151,260 +43.6% 2.25 US$7,090,335
2020-07-01 2020-06-30 B Purchase
588,235 +15.9%
17.00
US$9,999,995
588,235 +15.9% 17.00 US$9,999,995
2020-04-13 2020-04-03 S Sale
564 -0.0%
2.66
US$1,500
564 -0.0% 2.66 US$1,500
2020-02-05 2020-02-03 B Purchase
800,000 +30.2%
19.00
US$15,200,000
800,000 +30.2% 19.00 US$15,200,000
2020-01-28 2020-01-24 B Purchase
7,500,000 +62.5%
0.67
US$5,000,250
7,500,000 +62.5% 0.67 US$5,000,250
2019-07-24 2019-07-22 B Purchase
450,000 +12.0%
15.00
US$6,750,000
450,000 +12.0% 15.00 US$6,750,000
2019-06-25 2019-06-24 B Purchase
2,857,142 +65.4%
3.50
US$9,999,997
2,857,142 +65.4% 3.50 US$9,999,997
2019-05-13 2019-05-09 B Purchase
1,500,000 +51.0%
10.00
US$15,000,000
1,500,000 +51.0% 10.00 US$15,000,000
2019-05-13 2019-05-09 B Purchase
1,000,000 +51.6%
10.00
US$10,000,000
1,000,000 +51.6% 10.00 US$10,000,000
2019-05-09 2019-05-07 B Purchase
1,136,704 +124.1%
1.08
US$1,227,640
1,136,704 +124.1% 1.08 US$1,227,640
2019-02-19 2019-02-14 B Purchase
9,948,269 +39.8%
0.47
US$4,688,619
9,948,269 +39.8% 0.47 US$4,688,619